Personalis (PSNL) Total Non-Current Liabilities (2018 - 2026)
Personalis (PSNL) recorded quarterly Total Non-Current Liabilities of $70.1 million in Q1 2026, down 2.0% quarter-over-quarter from $71.5 million in Q4 2025, and up 9.47% on a YoY basis from $64.0 million in Q1 2025.
Personalis (PSNL) Total Non-Current Liabilities (2018 - 2026) Analysis & Trends
Personalis' Total Non-Current Liabilities history runs 9 years deep, the most recent figure standing at $70.1 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities rose 9.47% year-over-year to $70.1 million; the TTM figure through Mar 2026 stood at $70.1 million (up 9.47% YoY), while the FY2025 annual figure was $71.5 million, up 8.31% from the prior year.
- Total Non-Current Liabilities was $70.1 million for Q1 2026 at Personalis, down from $71.5 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $93.3 million in Q2 2022 to a low of $64.0 million in Q1 2025.
- Historically, Total Non-Current Liabilities has averaged $74.2 million across 5 years, with a median of $71.6 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Total Non-Current Liabilities surged 119.09% in 2022, then dropped 27.06% in 2024.
- A 5-year view of Total Non-Current Liabilities shows it stood at $74.2 million in 2022, then gained by 22.01% to $90.5 million in 2023, then decreased by 27.06% to $66.0 million in 2024, then advanced by 8.31% to $71.5 million in 2025, then decreased by 2.0% to $70.1 million in 2026.
- The last three Total Non-Current Liabilities figures came in at $70.1 million (Q1 2026), $71.5 million (Q4 2025), and $68.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | 6.97 Bn |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 56.93 Bn |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 25.03 Bn |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 529.54 Mn |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 5.45 Bn |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | 737.18 Mn |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 22.71 Bn |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 3.53 Bn |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 3.42 Bn |
| 10 | Personalis | 1.01 Bn | 780.57 Mn | 281,000.00 | 70.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.07 Mn |
| Dec 31, 2025 | 71.50 Mn |
| Sep 30, 2025 | 68.81 Mn |
| Jun 30, 2025 | 65.11 Mn |
| Mar 31, 2025 | 64.00 Mn |
| Dec 31, 2024 | 66.01 Mn |
| Sep 30, 2024 | 72.01 Mn |
| Jun 30, 2024 | 72.17 Mn |
| Mar 31, 2024 | 71.56 Mn |
| Dec 31, 2023 | 90.50 Mn |
| Sep 30, 2023 | 71.64 Mn |
| Jun 30, 2023 | 68.92 Mn |
| Mar 31, 2023 | 74.45 Mn |
| Dec 31, 2022 | 74.17 Mn |
| Sep 30, 2022 | 75.09 Mn |
| Jun 30, 2022 | 93.34 Mn |
| Mar 31, 2022 | 92.21 Mn |
| Dec 31, 2021 | 84.11 Mn |
| Sep 30, 2021 | 79.38 Mn |
| Jun 30, 2021 | 42.61 Mn |